Gastrointestinal Stents Market Analysis

Gastrointestinal Stents Market Analysis

To get key market trends

  Download Free Sample

Based on product, the gastrointestinal stents market is segmented as biliary stent, esophageal stent, colonic stent, pancreatic stent, and duodenal stent. The biliary stent dominated the market accounting over 38% business share in 2022. Biliary stents are medical devices used to treat various conditions affecting the biliary system, that include the bile ducts and gallbladder. Biliary stents are primarily used to relieve obstructions in the bile ducts. Patients with biliary obstructions often experience symptoms such as jaundice, pain, nausea, and vomiting. Biliary stents provide rapid relief from these symptoms by restoring the normal flow of bile and reducing pressure on the biliary system. Biliary stents play a critical role in improving patient outcomes by swiftly alleviating symptoms, preventing complications, and enhancing overall quality of life.
 

The ability of biliary stents to provide palliative care for patients with advanced biliary cancers significantly enhances the life expectance among patients. Biliary stents act as an essential component for comprehensive cancer care, fostering market growth. Advances in stent technology have led to the development of highly customizable biliary stents that can better fit patients' with specific anatomies and conditions.
 

Based on application, the gastrointestinal stents market is segmented as gastrointestinal cancer, biliary disease, colorectal cancer, stomach cancer and others. The biliary disease segment held a dominant market share and accounted for around USD 143.3 million in 2022. As the prevalence of biliary diseases such as gallstones, biliary strictures, and other obstructions increases, the number of patients requiring interventions like gastrointestinal stent placement also rises. Biliary diseases often require timely interventions to prevent complications and alleviate symptoms. Gastrointestinal stents serve as effective tools to manage biliary obstructions and maintain normal bile flow. Many biliary diseases can be managed effectively using minimally invasive procedures like biliary stent placement that helps to reduce trauma and helps in faster recovery.
 

As patients and healthcare providers become more informed, the demand for effective solutions like gastrointestinal stents is expected to grow at a significant pace. The aging population is more susceptible to various health conditions, including biliary diseases. As the global demographic shifts towards an older age group, the demand for interventions like stent placement to manage biliary issues is likely to increase. Hence, owing to several benefits offered by gastrointestinal stents in the diagnosis and treatment of biliary disease, the market is anticipated to witness a lucrative growth.
 

Based on material, the gastrointestinal stents market is segmented as self-expanding metal stents, plastic stents and other. The self-expanding metal stents segment accounting for around 45% market share in 2022. Self-expanding stents are designed to expand on their own once deployed, eliminating the need for manual inflation using a balloon. This simplifies the deployment process and reduces the risk of overexpansion or under expansion. Self-expanding stents are engineered to accurately conform to the shape and size of the target area within the gastrointestinal tract. This precise placement ensures optimal coverage of the obstruction or stricture. These stents are flexible and can adapt to the natural curves and contours of the gastrointestinal tract. This adaptability reduces the risk of stent migration and discomfort for the patient.
 

Self-expanding stents provide immediate relief by quickly restoring the patency of the gastrointestinal tract. Patients experience rapid alleviation of symptoms such as pain, vomiting, or difficulty swallowing. These stents are designed to maintain their expanded shape over time, providing effective and lasting relief from obstructions or strictures. Long-term patency helps avoid the need for frequent stent replacements. These benefits contribute to their effectiveness in managing obstructions, strictures, and other conditions within the gastrointestinal tract, making them a valuable tool in minimally invasive medical interventions.

Based on end-use, the gastrointestinal stents market is segmented as hospitals, ambulatory surgical centers and others. The hospitals segment exceeded USD 224.1 million in 2022. Hospitals are equipped with advanced diagnostic and interventional equipment, facilitating precise diagnosis, treatment planning, and stent placement procedures. Complex gastrointestinal cases, such as severe obstructions or strictures require specialized medical expertise available in hospital settings. Patients prefer inpatient admission to ensure comprehensive care from multidisciplinary teams. Hospitals offer a comprehensive range of medical services and specialties under one roof. Patients seeking treatment for gastrointestinal conditions, including stent placement, are more likely to choose hospitals due to the availability of various medical experts and resources. Gastrointestinal stent placement often requires the involvement of gastroenterologists, interventional radiologists, and surgeons.
 

Hospitals provide access to a multidisciplinary team of specialists, ensuring optimal care and successful stent procedures. Hospitals are equipped with state-of-the-art diagnostic and interventional equipment necessary for precise diagnosis, treatment planning, and stent placement. Hospitals provide continuous monitoring and comprehensive post-operative care, which is crucial for patients undergoing procedures like stent placement. Thus, availability and accessibility to advanced diagnosis and treatment incorporating gastrointestinal stents coupled with the rising prevalence of chronic ailments will surge patient visits to hospitals, thereby propelling the segment revenue.
 

North America gastrointestinal stents market was valued at USD 169.9 million in 2022. This high market share is ascribed to a variety of factors, including the presence of significant industry players, an increase in the number of patients suffering from gastrointestinal disorders, an expanding elderly population, among others. Gastrointestinal disorders, including obstructions, strictures, and other conditions that require stent placement, are prevalent in North America. The region's aging population and changing lifestyle patterns contribute to the growing incidence of such conditions. Gastrointestinal stents aid in the diagnosis and treatment of these chronic conditions thereby augmenting the market trends.
 

Increased awareness campaigns and healthcare education efforts in North America have led to early detection and intervention for gastrointestinal conditions. Early intervention often involves procedures like stent placement, thereby boosting market demand. North America boasts advanced healthcare infrastructure, including well-equipped hospitals, specialized medical centers, and state-of-the-art medical technology. This infrastructure supports the demand for gastrointestinal stents and their effective deployment. North America's relatively high healthcare spending and comprehensive insurance coverage make gastrointestinal stent procedures accessible to a larger portion of the population, further driving product demand.